Náš tým zkoumá základní mechanismy a převádí výsledky z laboratoře do klinické praxe — propojení preklinických modelů s klinickou perspektivou.
Výzkumný pracovník ICRC se zaměřením na translační medicínu. Propojuje preklinické poznatky s klinickou praxí napříč programy kardiologie, neurologie a onkologie.
Aktuálně vede / přispívá do interdisciplinárních projektů spojujících molekulární biologii, zobrazování a péči o pacienty ve Fakultní nemocnici u sv. Anny v Brně.
Evaluate unstable coronary plaques by new imaging methods
Test newly developed coronary stents and scaffolds in animal models and humans
Treatment of cardiogenic shock in patients with acute myocardial infarction
Zaměření výzkumu
The Acute Coronary Syndrome Research Group belongs among pioneers of primary percutaneous coronary intervention program in the Czech Republic and among one of the largest centers. The main activity of the ACS Research Group is interventional cardiology, treatment of acute and chronic coronary artery disease by percutaneous coronary interventions. The main research is focused on a new stent and scaffolds development, treatment of ST-Elevation Myocardial Infarction (STEMI) patients with multivessel disease, cardiogenic shock, antiaggregation therapy, Tako-tsubo cardiomyopathy, new imaging methods of coronary arteries and atherosclerotic plaque progression.
Technologické vybavení
Angiography System – Digital Subtraction Angiography (DSA)
Hlinomaz O, Tejc M, Sabbah M. Shockwave Lithotripsy vs Rotational Atherectomy: Mechanistic Differences From Optical Coherence Tomography. J Invasive Cardiol. 2021 Feb;33(2):E136-E137. Epub 2021 Jan 7. PMID: 33414357.
Hlinomaz O, Motovska Z, Knot J, Miklik R, Sabbah M, Hromadka M, Varvarovsky I, Dusek J, Svoboda M, Tousek F, Majtan B, Simek S, Branny M, Jarkovský J. Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial. J Clin Med. 2021 Oct 30;10(21):5103. doi: 10.3390/jcm10215103. PMID: 34768623; PMCID: PMC8584734.
Maugeri A, Hlinomaz O, Agodi A, Barchitta M, Kunzova S, Bauerova H, Sochor O, Medina-Inojosa JR, Lopez-Jimenez F, Vinciguerra M, Stokin GB, González-Rivas JP. Is Drinking Alcohol Really Linked to Cardiovascular Health? Evidence from the Kardiovize 2030 Project. Nutrients. 2020 Sep 17;12(9):2848. doi: 10.3390/nu12092848. PMID: 32957567; PMCID: PMC7551763.
Máchal J, Hlinomaz O, Kostolanská K, Peš O, Máchalová A, Šplíchal Z, Mot’ovská Z, Juřica J. CYP2C19 and CYP3A4 activity and ADP-induced platelet reactivity in prasugrel- or ticagrelor-treated STEMI patients: monocentric study in PRAGUE-18 trial participants. Xenobiotica. 2020 Aug;50(8):929-938. doi: 10.1080/00498254.2020.1731625. Epub 2020 Mar 30. PMID: 32065000.
Motovska Z, Hlinomaz O, Kala P, Hromadka M, Knot J, Varvarovsky I, Dusek J, Jarkovsky J, Miklik R, Rokyta R, Tousek F, Kramarikova P, Svoboda M, Majtan B, Simek S, Branny M, Mrozek J, Cervinka P, Ostransky J, Widimsky P; PRAGUE-18 Study Group. 1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor. J Am Coll Cardiol. 2018 Jan 30;71(4):371-381. doi: 10.1016/j.jacc.2017.11.008. Epub 2017 Nov 14. PMID: 29154813.